Udayavni Special

Vaccine patent waiver sets dangerous precedent, says Big Pharma

Will return to India in a few days, says Adar Poonawalla

”India was there for us and we will be there for them”: President Biden on India’s COVID-19 crisis

EU launches legal action against vaccine-maker AstraZeneca

Biden admin criticised for not releasing surplus COVID-19 vaccines to India

Serum Institute defends vaccine pricing, says initial rates based on advance funding

Pressure mounts on Biden admin to ship AstraZeneca vacc, other medical supplies to India

Questions about AstraZeneca Covid-19 jab linger

Reputation of AstraZeneca’s COVID vaccine marred by missteps

Countries to resume AstraZeneca jabs after EU agency deems it ‘safe’

EU drug agency: No indication AstraZeneca shot caused clots

AstraZeneca reassures safety of COVID-19 vaccine; says no evidence of increased risks

India reviews AstraZeneca Covid-19 vaccine side effects after concerns in Europe

India sending humanitarian assistance to drought-hit Madagascar

El Salvador getting its first vaccine from India

WHO chief raises questions about vaccines

AstraZeneca rejects ‘incorrect’ reports on Covid jab efficacy in elderly

Nepal approves AstraZeneca’s India-made COVID-19 vaccine for emergency use

COVID-19 vaccine to cost $3-4 to govt, $6-8 in pvt mkt says Serum Institute

CDSCO panel approves Oxford COVID-19 vaccine for emergency use

Oxford/AstraZeneca in ‘mix-match’ COVID-19 vaccine trial with Russia’s Sputnik

India ‘pharmacy of world,’ focusing on deeper ties in S&T: Swedish amb

Asian stocks fall amid unease about vaccine development

UK asks regulator to assess AZ-Oxford vaccine amid questions

AstraZeneca manufacturing error clouds vaccine study results

AstraZeneca promises Covid-19 vaccine at cost price worldwide

AstraZeneca, J&J resume Covid-19 vaccine trial in US

Serum Institute of India says ‘will resume Covid vaccine trials’ after drug controller’s nod

DCGI issues notice to Serum Institute after AstraZeneca suspends vaccine trial

Australia, AstraZeneca ink deal for COVID-19 vaccine; citizens to get it for free

British pharma giant ‘AstraZeneca’ all set to roll out COVID-19 vaccine in September

Covid-19: AstraZeneca may expose vaccine trial participants to virus

US Secures 300 Million Doses of Potential AstraZeneca Covid-19 Vaccine

Latest Additions

Aatma Nirbhar: Indian Oil Corporation’s role in making India progress towards petroleum self sufficiency

Meghalaya: Mushrooms that glow in the dark

West Bengal: Is the Left on its deathbed?

Maha NCP chief seeks Bharat Ratna for Karmaveer Bhaurao Patil

Strictly follow COVID-19 guidelines, top cop urges people

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.